The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The global kidney diseases market is on the cusp of remarkable growth, with the market size projected to increase from $92.26 billion in 2022 to $99.22 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 7.5%. Looking ahead, the market is poised to reach $128.15 billion by 2027, maintaining a substantial CAGR of 6.6%. This growth is underpinned by the surge in the incidence of kidney diseases and a transformative trend of integrating AI-driven tools for better patient outcomes.

Rising Incidence of Kidney Diseases

• Kidney diseases encompass a group of conditions that affect the function and structure of the kidneys.
• Medications for kidney disorders play a vital role in managing blood pressure, reducing protein loss, slowing kidney damage progression, symptom management, and preventing complications.

The Kidney Disease Epidemic

• In 2023, the American Kidney Fund reported that a staggering 37 million Americans have kidney disease.
• In 2020, around 130,000 Americans were newly diagnosed with kidney failure, underscoring the magnitude of the issue.
• Australia too, has seen an uptick in kidney replacement therapy cases, with a rise from 94 (per 100,000 population) in 2019 to 95.4 (per 100,000 population) in 2020, according to the Australian Institute of Health and Welfare.

Key Players in the Kidney Disease Market

• The kidney disease market boasts a roster of major players:
  • Pfizer Inc.
  • Johnson & Johnson Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi Aventis LLC
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Endo International plc.
  • Lupin Limited
  • Kissei Pharmaceutical Co. Ltd.

AI-Driven Tools: The Future of Kidney Disease Care

• One of the key trends transforming the kidney disease market is the integration of AI-driven tools.
• Healthcare companies are harnessing AI technology to enhance patient outcomes and consolidate their market presence.

Carenostics: Pioneering AI Integration

• In November 2022, Carenostics, a U.S.-based healthcare startup, introduced a groundbreaking product focused on the early identification of chronic kidney disease (CKD).
• This AI-powered product analyzes electronic health record (EHR) data to identify high-risk patients efficiently and accurately.
• Integrating AI-driven clinical decision support models into EHR systems empowers healthcare providers to take proactive measures, thus improving patient outcomes.

Diverse Market Segmentation

• The kidney disease market can be segmented based on various criteria:

1. By Treatment:
   • Medication
   • Dialysis
   • Surgery
   • Other Treatments
2. By Indication:
   • Acute Kidney Injury
   • Chronic Kidney Disease
   • End-Stage Renal Disease
   • Other Indications
3. By Route Of Administration:
   • Oral
   • Parenteral
4. By End-User:
   • Hospitals
   • Diagnostic Laboratories
   • Other End-Users

Global Market Dynamics

• In 2022, North America took the lead as the largest region in the kidney disease market, reflecting the region’s prominence in the healthcare industry.
• Looking ahead, Europe is poised to be the fastest-growing region, presenting a promising landscape for the kidney disease market in the coming years.

Read More On The Kidney Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Request for A Sample Of The Global Kidney Disease Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=11938&type=smp

The Table Of Content For The Kidney Disease Market Include:
1. Kidney Disease Market Executive Summary
2. Kidney Disease Market Segments
3. Kidney Disease Market Size And Kidney Disease Market Growth Rate
4. Key Kidney Disease Market Trends
5. Major Kidney Disease Market Drivers
……
25. Key Mergers And Acquisitions In The Kidney Disease Market
26. Top Kidney Disease Companies
27. Kidney Disease Market Opportunities And Strategies
28. Kidney Disease Market, Conclusions And Recommendations
29. Appendix

The Kidney Disease Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the kidney disease market.

View More Reports Related To The Market –
Kidney Dialysis Global Market Report 2023
Diabetic Kidney Disease Global Market Report 2023
Chronic Kidney Disease Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model